Antibody-drug conjugates in experimental models of HER2-positive gastric cancer and breast cancer with special reference to drug resistance
Starting year
2025
Granted funding
Negar Pourjamal 
6 000 €
Funder
Orion Research Foundation sr
Other information
Funding decision number
A1350
Fields of science
Genetics, developmental biology, physiology
Identified topics
cancer